Xcout Intel
ZyVersa Therapeutics, Inc.
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Subscribe to see ZyVersa Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ZyVersa Therapeutics, Inc. at a glance
ZyVersa Therapeutics, Inc. is a biotech company headquartered in Weston, United States. It is publicly listed (ZVSA) with a market capitalisation of $939,127. Xcout tracks 16 named people at ZyVersa Therapeutics, Inc., including Peter Wolfe (Chief Financial Officer & Secretary).
ZyVersa Therapeutics, Inc. leadership
- Peter WolfeChief Financial Officer & Secretary
- Karen A. CashmereChief Commercial Officer
- Stephen C. GloverCo-Founder, Chairman, Chief Executive Officer & President
- Christopher TwittyDirector
- Daniel J. O'ConnorDirector
- David S. BrionesDirector
10 more named people on record for ZyVersa Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Get ZyVersa Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ZyVersa Therapeutics, Inc. in Xcout Intel
- 16 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access